摘要:
The invention relates to the use of 2-imidazolyl substituted carbinols (I) and their pharmaceutically acceptable salts for the production of a medicament for the treatment or prophylaxis of ischaemic states. In (I), R1, R2 and R3 have the meanings disclosed in the claims.
摘要:
The invention relates to the use of 2-imidazolyl substituted carbinols (I) and their pharmaceutically acceptable salts for the production of a medicament for the treatment or prophylaxis of ischaemic states. In (I), R1, R2 and R3 have the meanings disclosed in the claims.
摘要:
The invention relates to benzoylguanidines of formula (I), wherein R2 stands for -Y-p-(C6H4)-R11, -Y-m-(C6-H4)-R11 or -Y-o-(C6H4)-R11; R11 represents (C1-C9)-heteroaryl, which is bonded by C or N and is substituted or unsubstituted with 1 to 3 substituents selected from the group consisting of F, Cl, CF3, CH3, methoxy, hydroxy, amino, methylamino, dimethylamino and benzyl; Y represents oxygen, -S- or NR12; R12 represents H or (C1-C4)-alkyl; R4 F, Cl, Br, I or C1-C4-alkyl; R1 and R3 are defined as per the claims. Said benzoylguanidines are suitable for use as anti-arrhythmic medicaments containing cardioprotective components for the prophylaxis and treatment of infarcts and for the treatment of angina pectoris. They also preventively inhibit the pathophysiological processes associated with the origination of defects caused by ischaemia, in particular during the triggering of ischaemically induced cardiac arrhythmia.
摘要:
The invention relates to heterocyclically substituted benzoylguanidine of formula (I), wherein the substituents R(1) to R(4) have the meanings given in the claims. These compounds (I) are suitable for use as anti-arrhythmic medicaments containing a cardio-protective component for infarct prophylaxis and infarct treatment and for the treatment of angina pectoris. The benyozlguanadines also preventively inhibit the pathophysiological processes arising from ischaemically induced traumas, in particular during the triggering of ischaemically induced cardiac arrhythmia.
摘要:
The invention relates to the use of 2-amino-3,4-dihydro-quinazolines of formula (I) and to their pharmaceutically compatible salts for producing a medicament for treating and preventing ischaemic conditions. R1, R2 and R3 have the meanings given in the claims.